SlideShare ist ein Scribd-Unternehmen logo
1 von 32
OLIGODENDROCYTES IN CNS DEVELOPMENT, DISEASE AND MYELIN REGENERATION  David Rowitch, MD, PhD Departments of Pediatrics and Neurosurgery Howard Hughes Medical Institute UCSF
Objectives ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Pelizaeus-Merzbacher Disease (PMD) Multiple sclerosis (MS)
Oligodendrocyte function in myelination  Saltatory (jumping) nerve conduction
Franklin and ffrench-Constant, 2008,  Nat. Neurosci. Rev. Two outcomes of MS lesions Repair Chronic  demyelination MS progression comprises (1) Autoimmune attack on OL, (2) inability to effectively repair in timely manner
OLIG1/2 in CNS Development and Disease Lu et al., 2000,  Neuron ; Zhou et al., 2000,  Neuron ; Lu et al., 2002,  Cell ; Zhou and Anderson, 2002;  Cell;  Takebayashi et al., 2002,  Curr. Biol. ;  Ligon, Huillard  et al., 2007,  Neuron; Arnett, Fancy et al., 2004, Science;  Sun et al., 20111,  Neuron ; Mehta et al., 2011,  Cancer Cell   Richard Lu  (UTSW) Chuck Stiles (DFCI) Heather Arnett (Amgen) Steve Fancy (UCSF) Robin Franklin (Cambridge) Embryonic Neural Tube
OLIG1 expression in multiple sclerosis Olig1 nuclear Olig1 cytoplasmic Unaffected white matter Edge MS plaque Arnett, Fancy  et al., 2004,  Science
Demyelinated axons OLP Focal area of OL death: demyelination Myelinated tissue  Lysolethicin gliotoxic injury model  Remyelination  Focal lysolecithin injection (Solochome cyanine)
Olig1  is required for remyelination Focal lysolecithin injection (Solochome cyanine)  Arnett, Fancy  et al., 2004,  Science Olig1 -/- Wild-type 14 dpl 28 dpl Ultra structure
Developmental perspective Chronic  demyelination “ Blocked” OLP are present in human MS lesions NG2 PDGFR  Pre-OL OLP OL Olig2 NG2 Olig1 (Nuclear) PLP Olig1 (Cytoplasmic) APC (CC1) O4 Nkx2.2 O1 APC Axin2 Are OLP blocked in MS?
What Programs Regulate Myelin Repair?
Genomic Screen: Remyelination kinetics Fancy et al., 2009,  Genes Dev Solochrome cyanine Tissue  array Genomic Expression Screen In situ  hybridization with 1040 probes White matter lesions OL differentiation 5dpl Myelination OLP recruitment 10dpl 14dpl ~50 Transcription factor- encoding genes  Transcription factor screen ~70% of TF genes in mammals ~50 genes with dynamic regulation during remyelination
Tcf4 (and Wnt reporter) expressed during  OLP development and remyelinating OLP Solochrome cyanine Tissue  array Genomic Expression Screen In situ  hybridization with 1040 probes White matter lesions Focal lysolecithin injection Focal ethidium bromide injection Dietary cuprizone Mouse SC Mouse CC Rat CCP OL differentiation 5dpl Myelination OLP recruitment 10dpl 14dpl ~50 Transcription factor- encoding genes  Genomic Screen Identifies Tcf4  Tcf4 is a mediator of Wnt signaling Fancy et al., 2009,  Genes Dev Tcf4   Olig2 Tcf4   Olig2 Tcf4   Olig2
Tcf4 mediates Wnt-Catenin Signaling  Inactive Activated Axin2
OLP markers unchanged; OL differentiation delayed Axin2, Nkd1, Notum  expression elevated  P4  Olig2-cre  X  (fl)DA-Catenin  vs. wild type spinal cord Affy mRNA array 430 2.0 Wnt-induced myelination delay
Fancy et al., 2009,  Genes Dev Wnt-induced remyelination delay WT Olig2cre X DA-  -Cat PLP Nkx2.2 10 dpl
Model: Wnt signaling in oligodendrocytes Pre-OL OLP OL APC Axin2? Active Wnt-Catenin signaling inhibits the transition to mature oligodendrocyte
[object Object],[object Object],[object Object]
Delayed remyelination in  Axin2 -/-  mice
Huang et al., 2009,  Nature Axin2  required to inhibit Wnt pathway
XAV939 stabilizes Axin2 in OLP  in vitro Huang et al., 2009,  Nature Fancy et al.,  Nature Neuroscience,  In press
Add XAV939 small molecule Wnt inhibitor… Wnt inhibitor accelerates remyelination Fancy et al.,  Nature Neuroscience,  In press OLP differentiation and remyelination accelerated ~4 days (Axin2-/- mice unaffected by XAV)
XAV939 does not affect inflammatory, gliotic response, OL death, OLP recruitment or proliferation Wnt inhibitor accelerates remyelination
Pre-OL OLP OL APC Axin2 Developmental perspective PDGFR  Olig2 NG2 Olig1 (Nuclear) PLP Olig1 (Cytoplasmic) APC (CC1) O4 Nkx2.2 O1 MS
NSC Replacement NSC Regulation Perspective on neural progenitor  transplant versus regulation Pre-OL OLP OL MS
Pelizaeus-Merzbacher Disease (PMD) ,[object Object],[object Object],[object Object],[object Object]
Normal (age 2 years) PMD (age 2 years) ,[object Object],Pelizaeus-Merzbacher Disease (PMD)
Restricted origins, diffuse migration and transplant of oligodendrocytes Pringle et al., 1993  Neuron ; Orentas et al., 1999  Development ; Rowitch, 2004  Nat. Neurosci. Rev. ; Windrem et al., 2008  Cell Stem Cell   Human OL in  Shi  mouse  brain. Work of Goldman lab, U. Rochester.
Phase I clinical trial for PMD ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object]
XAV939
Acknowledgements Steve Fancy Vivi Heine Emily Harrington Tracy Yuen John Silberis Jose Otero Eric Huang David Rowitch UCSF Richard Lu (UTSW) Heather Arnett (Amgen) Charles Stiles Dana-Farber Cancer Institute Chao Zhao Robin Franklin Cambridge University Saraid Billards Hannah Kenney Children ’s Hospital, Boston Stephen Huhn Stem Cells, Inc. Roel Nusse Stanford University

Weitere ähnliche Inhalte

Was ist angesagt?

Poster-Kelly Berger
Poster-Kelly BergerPoster-Kelly Berger
Poster-Kelly Berger
Kelly Berger
 
ADAR Enzyme's proposal
ADAR Enzyme's proposalADAR Enzyme's proposal
ADAR Enzyme's proposal
maryvi
 
Thyroxin regulates bdnf expression to promote survival of
Thyroxin regulates bdnf expression to promote survival ofThyroxin regulates bdnf expression to promote survival of
Thyroxin regulates bdnf expression to promote survival of
Smawi GH
 
Understanding Junk DNA
Understanding Junk DNAUnderstanding Junk DNA
Understanding Junk DNA
Douglas Arndt
 
140514 - HD synaptic characterization
140514 - HD synaptic characterization140514 - HD synaptic characterization
140514 - HD synaptic characterization
AJ Keefe
 
Plegable Luisa Naranjo
Plegable Luisa  NaranjoPlegable Luisa  Naranjo
Plegable Luisa Naranjo
LuisaNaranjoP
 

Was ist angesagt? (20)

Zinc finger
Zinc fingerZinc finger
Zinc finger
 
October 2012
October 2012October 2012
October 2012
 
Protein-RNA Complexes, ALS and Aging
Protein-RNA Complexes, ALS and AgingProtein-RNA Complexes, ALS and Aging
Protein-RNA Complexes, ALS and Aging
 
Poster-Kelly Berger
Poster-Kelly BergerPoster-Kelly Berger
Poster-Kelly Berger
 
Genome Sequencing in Finger Millet
Genome Sequencing in Finger MilletGenome Sequencing in Finger Millet
Genome Sequencing in Finger Millet
 
nrn_bdnf_poster
nrn_bdnf_posternrn_bdnf_poster
nrn_bdnf_poster
 
ADAR Enzyme's proposal
ADAR Enzyme's proposalADAR Enzyme's proposal
ADAR Enzyme's proposal
 
Stem Cell Research Powerpoint
Stem Cell Research PowerpointStem Cell Research Powerpoint
Stem Cell Research Powerpoint
 
Thyroxin regulates bdnf expression to promote survival of
Thyroxin regulates bdnf expression to promote survival ofThyroxin regulates bdnf expression to promote survival of
Thyroxin regulates bdnf expression to promote survival of
 
Understanding Junk DNA
Understanding Junk DNAUnderstanding Junk DNA
Understanding Junk DNA
 
140514 - HD synaptic characterization
140514 - HD synaptic characterization140514 - HD synaptic characterization
140514 - HD synaptic characterization
 
Junk DNA And The Human Genome
Junk DNA And The Human GenomeJunk DNA And The Human Genome
Junk DNA And The Human Genome
 
Natalizio_MBOC_2013
Natalizio_MBOC_2013Natalizio_MBOC_2013
Natalizio_MBOC_2013
 
Plegable Luisa Naranjo
Plegable Luisa  NaranjoPlegable Luisa  Naranjo
Plegable Luisa Naranjo
 
Zeine et al. J. Neuroscience Research 2001
Zeine et al. J. Neuroscience Research 2001Zeine et al. J. Neuroscience Research 2001
Zeine et al. J. Neuroscience Research 2001
 
Bioinformatic data analysis – comparison from three human studies using diffe...
Bioinformatic data analysis – comparison from three human studies using diffe...Bioinformatic data analysis – comparison from three human studies using diffe...
Bioinformatic data analysis – comparison from three human studies using diffe...
 
ROLE OF NETosis IN PATHOLOGICAL AND TOXICOLOGICAL CONDITIONS.
ROLE OF NETosis IN PATHOLOGICAL AND TOXICOLOGICAL CONDITIONS.ROLE OF NETosis IN PATHOLOGICAL AND TOXICOLOGICAL CONDITIONS.
ROLE OF NETosis IN PATHOLOGICAL AND TOXICOLOGICAL CONDITIONS.
 
MITOCHONDRIAL COMPLEX 1 ROLE IN PARKINSONISM
MITOCHONDRIAL COMPLEX 1 ROLE IN PARKINSONISMMITOCHONDRIAL COMPLEX 1 ROLE IN PARKINSONISM
MITOCHONDRIAL COMPLEX 1 ROLE IN PARKINSONISM
 
Folding
FoldingFolding
Folding
 
Nets (NEUTROPHILL EXTEACELLULAR TRAPS) in wound healing mohit
Nets (NEUTROPHILL EXTEACELLULAR TRAPS) in wound healing   mohitNets (NEUTROPHILL EXTEACELLULAR TRAPS) in wound healing   mohit
Nets (NEUTROPHILL EXTEACELLULAR TRAPS) in wound healing mohit
 

Ähnlich wie Rowitch, David

The brain eater
The brain eaterThe brain eater
The brain eater
Lex Luthor
 
Zelman vladimir exploring new frontiers of brain preservation and protection
Zelman vladimir exploring new frontiers of brain preservation and protectionZelman vladimir exploring new frontiers of brain preservation and protection
Zelman vladimir exploring new frontiers of brain preservation and protection
igorod
 
Development and implementation of a novel interactome platform in studies on ...
Development and implementation of a novel interactome platform in studies on ...Development and implementation of a novel interactome platform in studies on ...
Development and implementation of a novel interactome platform in studies on ...
Ewelina Maliszewska-Cyna, PhD
 
Positron emission tomographic scan
Positron emission tomographic scanPositron emission tomographic scan
Positron emission tomographic scan
Prashant Makhija
 
Scientifi c Journal of Multiple Sclerosis
Scientifi c Journal of Multiple SclerosisScientifi c Journal of Multiple Sclerosis
Scientifi c Journal of Multiple Sclerosis
SciRes Literature LLC. | Open Access Journals
 

Ähnlich wie Rowitch, David (20)

Prion diseases
Prion diseasesPrion diseases
Prion diseases
 
Genes in complex neurological disorders
Genes in complex neurological disordersGenes in complex neurological disorders
Genes in complex neurological disorders
 
Dr Gerry Chader - AGM 2011 - Research Advancements
Dr Gerry Chader - AGM 2011 - Research AdvancementsDr Gerry Chader - AGM 2011 - Research Advancements
Dr Gerry Chader - AGM 2011 - Research Advancements
 
Progressive myoclonic epilepsy
Progressive myoclonic epilepsyProgressive myoclonic epilepsy
Progressive myoclonic epilepsy
 
Progressive myoclonic epilepsy
Progressive myoclonic epilepsyProgressive myoclonic epilepsy
Progressive myoclonic epilepsy
 
Neuroimmunology update
Neuroimmunology updateNeuroimmunology update
Neuroimmunology update
 
The brain eater
The brain eaterThe brain eater
The brain eater
 
The brain eater (Creutzfeldt Jakob Disease)
The brain eater (Creutzfeldt Jakob Disease)The brain eater (Creutzfeldt Jakob Disease)
The brain eater (Creutzfeldt Jakob Disease)
 
Mfn2 hereditary motor and sensory neuropathy
Mfn2 hereditary motor and sensory neuropathyMfn2 hereditary motor and sensory neuropathy
Mfn2 hereditary motor and sensory neuropathy
 
Tuberous Sclerosis - Orrin Devinsky, MD
Tuberous Sclerosis - Orrin Devinsky, MDTuberous Sclerosis - Orrin Devinsky, MD
Tuberous Sclerosis - Orrin Devinsky, MD
 
Zelman vladimir exploring new frontiers of brain preservation and protection
Zelman vladimir exploring new frontiers of brain preservation and protectionZelman vladimir exploring new frontiers of brain preservation and protection
Zelman vladimir exploring new frontiers of brain preservation and protection
 
2 2. hyung min chung ppt
2 2. hyung min chung ppt2 2. hyung min chung ppt
2 2. hyung min chung ppt
 
Development and implementation of a novel interactome platform in studies on ...
Development and implementation of a novel interactome platform in studies on ...Development and implementation of a novel interactome platform in studies on ...
Development and implementation of a novel interactome platform in studies on ...
 
Tryptophan and madness
Tryptophan and madnessTryptophan and madness
Tryptophan and madness
 
Positron emission tomographic scan
Positron emission tomographic scanPositron emission tomographic scan
Positron emission tomographic scan
 
The future: Presentation by Gavin Giovannoni
The future: Presentation by Gavin GiovannoniThe future: Presentation by Gavin Giovannoni
The future: Presentation by Gavin Giovannoni
 
Lupus neuropsiquiatria
Lupus neuropsiquiatriaLupus neuropsiquiatria
Lupus neuropsiquiatria
 
Scientifi c Journal of Multiple Sclerosis
Scientifi c Journal of Multiple SclerosisScientifi c Journal of Multiple Sclerosis
Scientifi c Journal of Multiple Sclerosis
 
KDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryKDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discovery
 
101111 als
101111 als101111 als
101111 als
 

Mehr von National Neurotrauma Symposium (20)

Zasler, Nathan
Zasler, NathanZasler, Nathan
Zasler, Nathan
 
Zafonte, Ross
Zafonte, RossZafonte, Ross
Zafonte, Ross
 
Youcha, Vicki
Youcha, VickiYoucha, Vicki
Youcha, Vicki
 
Yonas, Howard
Yonas, HowardYonas, Howard
Yonas, Howard
 
Ungerstedt, Urban
Ungerstedt, UrbanUngerstedt, Urban
Ungerstedt, Urban
 
Timmons, Shelly
Timmons, ShellyTimmons, Shelly
Timmons, Shelly
 
Svetlov, Stanislav
Svetlov, StanislavSvetlov, Stanislav
Svetlov, Stanislav
 
Sullivan, Patrick
Sullivan, PatrickSullivan, Patrick
Sullivan, Patrick
 
Stewart, William
Stewart, WilliamStewart, William
Stewart, William
 
Smith, Doug H. - handout
Smith, Doug H. - handoutSmith, Doug H. - handout
Smith, Doug H. - handout
 
Smith, Doug H.
Smith, Doug H.Smith, Doug H.
Smith, Doug H.
 
Sanchez, Justin
Sanchez, JustinSanchez, Justin
Sanchez, Justin
 
Rezai, Ali
Rezai, AliRezai, Ali
Rezai, Ali
 
Razumovsky, Alexander
Razumovsky, AlexanderRazumovsky, Alexander
Razumovsky, Alexander
 
Povlishock, John
Povlishock, JohnPovlishock, John
Povlishock, John
 
Peckham, Hunter
Peckham, HunterPeckham, Hunter
Peckham, Hunter
 
Widerstrom noga talk 7-12_11
Widerstrom noga talk 7-12_11Widerstrom noga talk 7-12_11
Widerstrom noga talk 7-12_11
 
Noble, Marc
Noble, MarcNoble, Marc
Noble, Marc
 
Mukherjee, Pratik
Mukherjee, PratikMukherjee, Pratik
Mukherjee, Pratik
 
Meehan, William
Meehan, WilliamMeehan, William
Meehan, William
 

Kürzlich hochgeladen

Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 

Kürzlich hochgeladen (20)

Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
A Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusA Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source Milvus
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 

Rowitch, David

  • 1. OLIGODENDROCYTES IN CNS DEVELOPMENT, DISEASE AND MYELIN REGENERATION David Rowitch, MD, PhD Departments of Pediatrics and Neurosurgery Howard Hughes Medical Institute UCSF
  • 2.
  • 3.
  • 4. Oligodendrocyte function in myelination Saltatory (jumping) nerve conduction
  • 5. Franklin and ffrench-Constant, 2008, Nat. Neurosci. Rev. Two outcomes of MS lesions Repair Chronic demyelination MS progression comprises (1) Autoimmune attack on OL, (2) inability to effectively repair in timely manner
  • 6. OLIG1/2 in CNS Development and Disease Lu et al., 2000, Neuron ; Zhou et al., 2000, Neuron ; Lu et al., 2002, Cell ; Zhou and Anderson, 2002; Cell; Takebayashi et al., 2002, Curr. Biol. ; Ligon, Huillard et al., 2007, Neuron; Arnett, Fancy et al., 2004, Science; Sun et al., 20111, Neuron ; Mehta et al., 2011, Cancer Cell Richard Lu (UTSW) Chuck Stiles (DFCI) Heather Arnett (Amgen) Steve Fancy (UCSF) Robin Franklin (Cambridge) Embryonic Neural Tube
  • 7. OLIG1 expression in multiple sclerosis Olig1 nuclear Olig1 cytoplasmic Unaffected white matter Edge MS plaque Arnett, Fancy et al., 2004, Science
  • 8. Demyelinated axons OLP Focal area of OL death: demyelination Myelinated tissue Lysolethicin gliotoxic injury model Remyelination Focal lysolecithin injection (Solochome cyanine)
  • 9. Olig1 is required for remyelination Focal lysolecithin injection (Solochome cyanine) Arnett, Fancy et al., 2004, Science Olig1 -/- Wild-type 14 dpl 28 dpl Ultra structure
  • 10. Developmental perspective Chronic demyelination “ Blocked” OLP are present in human MS lesions NG2 PDGFR  Pre-OL OLP OL Olig2 NG2 Olig1 (Nuclear) PLP Olig1 (Cytoplasmic) APC (CC1) O4 Nkx2.2 O1 APC Axin2 Are OLP blocked in MS?
  • 11. What Programs Regulate Myelin Repair?
  • 12. Genomic Screen: Remyelination kinetics Fancy et al., 2009, Genes Dev Solochrome cyanine Tissue array Genomic Expression Screen In situ hybridization with 1040 probes White matter lesions OL differentiation 5dpl Myelination OLP recruitment 10dpl 14dpl ~50 Transcription factor- encoding genes Transcription factor screen ~70% of TF genes in mammals ~50 genes with dynamic regulation during remyelination
  • 13. Tcf4 (and Wnt reporter) expressed during OLP development and remyelinating OLP Solochrome cyanine Tissue array Genomic Expression Screen In situ hybridization with 1040 probes White matter lesions Focal lysolecithin injection Focal ethidium bromide injection Dietary cuprizone Mouse SC Mouse CC Rat CCP OL differentiation 5dpl Myelination OLP recruitment 10dpl 14dpl ~50 Transcription factor- encoding genes Genomic Screen Identifies Tcf4 Tcf4 is a mediator of Wnt signaling Fancy et al., 2009, Genes Dev Tcf4 Olig2 Tcf4 Olig2 Tcf4 Olig2
  • 14. Tcf4 mediates Wnt-Catenin Signaling Inactive Activated Axin2
  • 15. OLP markers unchanged; OL differentiation delayed Axin2, Nkd1, Notum expression elevated P4 Olig2-cre X (fl)DA-Catenin vs. wild type spinal cord Affy mRNA array 430 2.0 Wnt-induced myelination delay
  • 16. Fancy et al., 2009, Genes Dev Wnt-induced remyelination delay WT Olig2cre X DA-  -Cat PLP Nkx2.2 10 dpl
  • 17. Model: Wnt signaling in oligodendrocytes Pre-OL OLP OL APC Axin2? Active Wnt-Catenin signaling inhibits the transition to mature oligodendrocyte
  • 18.
  • 19. Delayed remyelination in Axin2 -/- mice
  • 20. Huang et al., 2009, Nature Axin2 required to inhibit Wnt pathway
  • 21. XAV939 stabilizes Axin2 in OLP in vitro Huang et al., 2009, Nature Fancy et al., Nature Neuroscience, In press
  • 22. Add XAV939 small molecule Wnt inhibitor… Wnt inhibitor accelerates remyelination Fancy et al., Nature Neuroscience, In press OLP differentiation and remyelination accelerated ~4 days (Axin2-/- mice unaffected by XAV)
  • 23. XAV939 does not affect inflammatory, gliotic response, OL death, OLP recruitment or proliferation Wnt inhibitor accelerates remyelination
  • 24. Pre-OL OLP OL APC Axin2 Developmental perspective PDGFR  Olig2 NG2 Olig1 (Nuclear) PLP Olig1 (Cytoplasmic) APC (CC1) O4 Nkx2.2 O1 MS
  • 25. NSC Replacement NSC Regulation Perspective on neural progenitor transplant versus regulation Pre-OL OLP OL MS
  • 26.
  • 27.
  • 28. Restricted origins, diffuse migration and transplant of oligodendrocytes Pringle et al., 1993 Neuron ; Orentas et al., 1999 Development ; Rowitch, 2004 Nat. Neurosci. Rev. ; Windrem et al., 2008 Cell Stem Cell Human OL in Shi mouse brain. Work of Goldman lab, U. Rochester.
  • 29.
  • 30.
  • 32. Acknowledgements Steve Fancy Vivi Heine Emily Harrington Tracy Yuen John Silberis Jose Otero Eric Huang David Rowitch UCSF Richard Lu (UTSW) Heather Arnett (Amgen) Charles Stiles Dana-Farber Cancer Institute Chao Zhao Robin Franklin Cambridge University Saraid Billards Hannah Kenney Children ’s Hospital, Boston Stephen Huhn Stem Cells, Inc. Roel Nusse Stanford University